Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station

Core Insights - Prenetics Global Limited has signed a Memorandum of Understanding (MOU) with Metavisionaries and Space Application Services to establish a strategic investment and a five-year research agreement focused on space-related health advancements [1][2] - The initial research project will be conducted in collaboration with the Botnar Research Institute at the University of Oxford, targeting accelerated aging in space [2] - The first research cube from Prenetics is set to be launched aboard SpaceX to the International Space Station (ISS) in the fourth quarter of 2024 [1] Company Developments - Dr. James L. Green and Dr. Tara Ruttley, both former NASA scientists, will join the Prenetics Scientific Advisory Board, enhancing the company's expertise in space research [4] - Danny Yeung, CEO of Prenetics, will also join the Board of Directors at Metavisionaries, strengthening the strategic partnership [4] - Prenetics is committed to leveraging space research to drive health innovations on Earth, as stated by its CEO [3] Research Focus - The collaboration aims to explore cellular solutions that promote rejuvenation and combat accelerated aging caused by the zero-gravity environment of space [2] - The research has the potential to lead to significant advancements in healthcare, enhancing cellular health and longevity for individuals on Earth [2] Strategic Goals - The partnership is part of a broader initiative to build a space ecosystem by engaging non-space industry partners in innovation and exploration [2] - The establishment of a Space Innovation Lab within the UAE Space Agency is a key component of this initiative [1]